CA
NZ
UK
AU
IND
US
Dell Technologies Inc. (NYSE: DELL) posted quarterly revenue of $46,971 million ($47.0 billion), a 58% year-over-year increase for the three months ended July 31, 2026. GAAPDiluted Earnings per Shareclimbed 273% year over year to $6.34, while non-GAAP diluted EPS rose 203% to $7.04. GAAPNet …
Fly-E Group’s quarterlyRevenuefell 48.4% to $2,748,140 from $5,328,198, while net loss widened 96.1% to $3,939,083 and loss per share was $2.41. The results matter to investors becauseGross Profitof $299,864 was below total operating expenses of $3,836,135, leaving a $3,536,271 operating loss.Key HighlightsFly-E Group’s net …
GitLab Inc. (NASDAQ: GTLB) generated $286.3 million in revenue during the second quarter of fiscal year 2027 ended July 31, 2026, an increase of 21% year-over-year. GAAP net loss attributable to GitLab was $36.8 million, while non-GAAP net income attributable to GitLab reached $42.1 …
Roland Thomas Kelly, Chief Legal Officer and General Counsel of Velocity Financial, Inc. (NYSE:VEL), filed a Form 4 on September 1, 2026, disclosing the sale of 1,600 shares of common stock on that same date pursuant to a Rule 10b5-1 trading plan.
Stephen Kenneth Parker, Executive Vice President, President and CEO of Boeing Defense, Space and Security, filed a Form 4 with the SEC on September 1, 2026, disclosing a change in beneficial ownership of Boeing Co common stock dated August 28, 2026.
Scott D. Lipesky, Executive Vice President and Chief Operating Officer of Abercrombie & Fitch Co /DE/ (NYSE:ANF), filed a Form 4 on September 1, 2026, reporting the sale of 5,000 shares of Class A Common Stock on August 28, 2026.
Jay Rust, Executive Vice President and Chief HR Officer of Abercrombie & Fitch Co /DE/, filed a Form 4 on September 1, 2026, disclosing the sale of 5,000 shares of Class A Common Stock on August 28, 2026.
A Form 4 filed with the SEC on September 1, 2026 discloses that Kenneth B. Robinson, a director of Abercrombie & Fitch Co /DE/ (NYSE:ANF), sold 800 shares of Class A Common Stock on August 28, 2026.
Gwenn Hansen, Chief Scientific Officer of Nurix Therapeutics, Inc. (NASDAQ:NRIX), filed a Form 4 on September 1, 2026, disclosing the exercise of stock options and a same-day sale of 1,452 shares of common stock pursuant to a Rule 10b5-1 trading plan.
A Form 4 filed on September 1, 2026, discloses that William Gossman, a director of nLIGHT, Inc. (NASDAQ:LASR), exercised stock options and sold 15,000 shares of common stock on August 28, 2026, pursuant to a Rule 10b5-1 trading plan.
Please wait processing your request...